"Can MSB benefit from this 'More Patient Focused and Less Adversarial' FDA review process?"
Should yes. But depends on any hidden agenda and who (BP) may be in the ear of the FDA.
Who knows what is happening behind the curtain.
V.
2024 Here we go again., page-649
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.12 |
Change
0.015(1.36%) |
Mkt cap ! $1.278B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.16 | $1.10 | $7.169M | 6.411M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 7296 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 43068 | 1 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |